Cu<sub>2–<i>x</i></sub>O@Ti<sub>3</sub>C<sub>2</sub> Integrated Photothermal Nanofibers with Antibacterial, Anti-Inflammatory, and Hemostatic Properties for Promoting Infected Diabetic Wound Healing
Infected diabetic wounds represent a significant challenge in clinical care due to persistent inflammation and impaired healing. To address these issues, the development of novel wound dressings with both antibacterial and reactive oxygen species (ROS) scavenging properties is essential. Herein, we prepare a novel wound dressing composed of Cu<sub>2-<i>x</i></sub>O nanoparticles decorated on Ti<sub>3</sub>C<sub>2</sub> MXene (Cu<sub>2-<i>x</i></sub>O@Ti<sub>3</sub>C<sub>2</sub>) and integrate it into a poly(vinyl alcohol) (PVA) matrix to form electrospun nanofibers (Cu<sub>2-<i>x</i></sub>O@Ti<sub>3</sub>C<sub>2</sub>@PVA). Cu<sub>2-<i>x</i></sub>O@Ti<sub>3</sub>C<sub>2</sub> exhibits remarkable photothermal conversion efficiency and effective ROS scavenging properties. In vitro experiments demonstrated that Cu<sub>2-<i>x</i></sub>O@Ti<sub>3</sub>C<sub>2</sub> effectively kills bacteria upon near-infrared (NIR) irradiation, which can be attributed to the photothermal therapy (PTT) effect of Ti<sub>3</sub>C<sub>2</sub>. At the same time, the ROS scavenging abilities of both Ti<sub>3</sub>C<sub>2</sub> and Cu<sub>2-<i>x</i></sub>O endow Cu<sub>2-<i>x</i></sub>O@Ti<sub>3</sub>C<sub>2</sub> with significant in vitro anti-inflammatory effects. As a promising wound dressing, in vivo studies validated the high efficacy of Cu<sub>2-<i>x</i></sub>O@Ti<sub>3</sub>C<sub>2</sub>@PVA in promoting hemostasis, exerting antibacterial activity, reducing inflammation, and accelerating the healing process of diabetic wounds. This innovative approach provides a comprehensive solution to the multifaceted challenges of diabetic wound healing and paves the way for improved clinical outcomes.
Authors
- Linghui Dian (ORCID: https://orcid.org/0000-0002-4322-4632)
- Jinxiu Liu (ORCID: https://orcid.org/0009-0001-3820-8195)
- Ning Guo (ORCID: https://orcid.org/0000-0001-5305-5636)
- Ying Kuang (ORCID: https://orcid.org/0000-0003-2142-8455)
- Zhongjia Liu
- Jia Chen (ORCID: https://orcid.org/0000-0002-6350-6610)
- Tao Liao (ORCID: https://orcid.org/0000-0003-2534-4304)
- Cao Li (ORCID: https://orcid.org/0000-0002-3500-340X)
- Yun Liu
- Guolie Xie
Institutions
- Guangdong Medical College (CN)
- Dongguan People’s Hospital (CN)
- Hubei University of Technology (CN)
Publication Details
- Journal
- ACS Biomaterials Science & Engineering
- Published
- 2025-02-22
- DOI
- https://doi.org/10.1021/acsbiomaterials.4c01936
- Citations
- 3
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 2.02
Funders
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province